+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Infection Drug"

Eye Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Eye Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Sternal Wound Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Sternal Wound Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Staphylococcus Aureus Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Staphylococcus Aureus Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Post-surgical Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Post-surgical Infection - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
CNS Bacterial Infections - Pipeline Insight, 2025 - Product Thumbnail Image

CNS Bacterial Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Staphylococcal Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Staphylococcal Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
From
H1N1 Infection - Pipeline Insight, 2025 - Product Thumbnail Image

H1N1 Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Hepatitis C Virus Infection- Pipeline Insight, 2025 - Product Thumbnail Image

Hepatitis C Virus Infection- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Nontuberculous Mycobacterial Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Nontuberculous Mycobacterial Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Hepatitis C Virus Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Hepatitis C Virus Infection - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 75 Pages
  • Global
From
From
BK Virus (BKV) Infections - Pipeline Insight, 2025 - Product Thumbnail Image

BK Virus (BKV) Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
Influenza Virus B Infections-Pipeline Insight, 2025 - Product Thumbnail Image

Influenza Virus B Infections-Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Pseudomonal Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Pseudomonal Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 50 Pages
  • Global
From
Chronic Pulmonary Infections- Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Pulmonary Infections- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs. Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more